Rachel Schwartz
University of Illinois at Urbana–Champaign
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rachel Schwartz.
Veterinary Immunology and Immunopathology | 1998
Federico A. Zuckermann; Robert J. Husmann; Rachel Schwartz; Julie Brandt; Enric Mateu de Antonio; Stephen Martin
Cell-mediated immunity is a major component of the host defense system against viral infections. Since interleukin (IL)-12 has been shown to be a potent stimulus for the in vivo generation of interferon-gamma (IFN-gamma)-producing T cells (i.e. Th-1 cells) in laboratory animals, we evaluated the effect of IL-12 on the cellular immune response of pigs to vaccination against pseudorabies virus (PrV), a herpesvirus of swine. The magnitude of the cellular immune response was measured by IFN-gamma ELISPOT analysis of peripheral blood mononuclear cells (PBMC) from pigs which had been immunized twice, at 2-week intervals, with either, modified live virus (MLV) alone or with a commercial inactivated PrV vaccine with or without the coadministration of human recombinant IL-12 (HrIL-12). No significant differences in the titer of virus-neutralizing antibodies or in the intensity of the virus-specific lymphoproliferative response among the different treatment groups was observed. However, the number of virus-specific IFN-gamma-producing cells among PBMC isolated from animals receiving the MLV vaccine was on average 3.5 times more than animals immunized with the inactivated vaccine (P = 0.01). Administration of the inactivated vaccine and IL-12 induced a two-fold higher frequency of virus-specific IFN-gamma-producing cells from that induced by the inactivated vaccine alone (P < 0.05). Despite this enhancement, the level of protection from lethal PrV challenge provided by the inactivated vaccine in combination with IL-12 was the same as that induced by the inactivated vaccine alone. Both of these vaccination regimes provided significantly lower levels of protection than those afforded by the MLV vaccine. This study demonstrates that an inactivated PrV vaccine is a poor inducer of virus-specific IFN-gamma-producing cells and that this response can be enhanced by administration of exogenous IL-12. The data provides evidence of a dichotomy in the humoral and cellular immune responses of pigs to a viral antigen and implies the existence of a Th-1/Th-2 type regulation of the anti-viral immune response in pigs.
Journal of Accounting Research | 2001
Nicholas Dopuch; Ronald R. King; Rachel Schwartz
Accounting Organizations and Society | 2007
Mark E. Peecher; Rachel Schwartz; Ira Solomon
Contemporary Accounting Research | 2003
Nicholas Dopuch; Ronald R. King; Rachel Schwartz
Review of Quantitative Finance and Accounting | 1998
Rachel Schwartz
Archive | 1996
Rachel Schwartz; Ronald R. King
Contemporary Accounting Research | 1999
Ronald R. King; Rachel Schwartz
The Accounting Review | 2000
Ronald R. King; Rachel Schwartz
Asia-pacific Journal of Accounting & Economics | 2004
Nicholas Dopuch; Ronald R. King; Rachel Schwartz
Archive | 1997
Rachel Schwartz; Ronald R. King